IL-2, IL-6 and IL-8 levels remain unaltered in the course of immunosuppressive therapy after renal transplantation

Cytokines regulate the immune reactions elicited by renal transplantation (RT). This study was designed to investigate the blood serum levels of IL-2, IL-6, IL-8 in 25 RT patients (10 female and 15 male, mean 5.4±2.7 yrs after RT) three times over a six-month period during standard immunosuppressive therapy with cyclosporine A, azathioprine and prednisolone. The levels of IL-2, IL-6 and IL-8 were tested with ELISA Quantikine Human Interleukin Immunoassay (R&D Systems, detection level 7,0.7 and 10 pg/cm3, respectively). There was no significant alternation of blood serum levels of IL-2, IL-6 and IL-8 in the study patients.

[1]  J. Rysz,et al.  Integrin CD11a/CD18, CD11b/CD18 and CD69 expression in patients after renal transplantation , 2007 .

[2]  J. Małyszko,et al.  Original paper Prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary interventions in everyday clinical practice , 2006 .

[3]  M. Banach,et al.  Increased Levels of Soluble TNF-α Receptors and Cellular Adhesion Molecules in Patients Undergoing Bioincompatible Hemodialysis , 2006, American Journal of Nephrology.

[4]  M. Banach,et al.  TNF-α priming effect on polymorphonuclear leukocyte reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients , 2006, Archivum Immunologiae et Therapiae Experimentalis.

[5]  M. Banach,et al.  Blood Serum Levels of IL-2, IL-6, IL-8, TNF-α and IL-1β in Patients on Maintenance Hemodialysis , 2006 .

[6]  R. Oberbauer,et al.  The influence of organ donor factors on early allograft function , 2003, Current opinion in urology.

[7]  M. Alegre,et al.  Costimulatory molecules as targets for the induction of transplantation tolerance. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  M. Boratyńska.  [Monitoring of interleukin-8 in urine and in serum of patients after kidney transplantation]. , 1998, Przeglad lekarski.

[9]  K. Budde,et al.  Interleukin-8 expression in patients after renal transplantation. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  K. Budde,et al.  Interleukin-6 expression after renal transplantation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  R. Waldherr,et al.  Cytokines and growth factors in renal disease. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  J. Forsythe,et al.  THE VALUE OF POSTTRANSPLANT MONITORING OF INTERLEUKIN (IL)-2, IL‐3, IL‐4, IL‐6, IL‐8, AND SOLUBLE CD23 IN THE PLASMA OF RENAL ALLOGRAFT RECIPIENTS , 1995, Transplantation.

[13]  P. Jungers,et al.  Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. , 1995, Journal of immunology.

[14]  D. Nelson,et al.  An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection. , 1994, American Journal of Kidney Diseases.

[15]  B. Descamps-Latscha,et al.  Elevated circulating levels of interleukin-6 in patients with chronic renal failure. , 1991, Kidney international.

[16]  K. Oka,et al.  Recovery of Decreased Ability of Peripheral-Blood Mononuclear Cells from Chronic Renal Failure to Produce Interleukin-1α and β after Renal Transplantation , 1991 .

[17]  J. Whicher,et al.  Cytokines in disease. , 1990, Clinical chemistry.

[18]  H. Dobbelstein.  Immune system to uremia. , 1976, Nephron.